Comparing the oncologic outcomes of local tumor destruction vs. local tumor excision vs. partial nephrectomy in T1a solid renal masses: a population-based cohort study from the SEER database
Open Access
- 10 April 2024
- journal article
- research article
- Published by Wolters Kluwer Health in International Journal of Surgery
- Vol. 110 (8) , 4571-4580
Abstract
Background: There are few large-scale analyses comparing local tumor destruction (LTD) or local tumor enucleation/excision (LTE) relative to partial nephrectomy (PN) for patients with T1a renal masses in terms of cancer-specific survival (CSS) and overall survival (OS). The authors aimed to compare CSS and OS after LTD versus LTE versus PN. Materials and methods: Within the Surveillance, Epidemiology, and End Results (SEER) database (2000–2019), the authors identified patients with clinical T1a renal masses and histologically confirmed kidney cancer treated with LTD, LTE, or PN. After 1:1 ratio propensity score matching (PSM), comparisons between the groups were conducted. Kaplan–Meier analysis and log-rank tests were used to compare survival in the matched population. Results: In the overall cohort of 3717 LTD patients versus 1993 LTE patients versus 26 935 PN patients, 77.3% of LTD-treated patients and 74.4% of LTE-treated patients were over 60 years old, while only 50.3% of PN-treated patients were over 60 years old. PN was more strongly associated with CSS [hazard ratio ((HR)=1.276, PPP=0.230) and OS (HR=0.888, P=0.002) than was LTE, not only in the PSM cohort but also in the subgroups of patients with a tumor size ≤3 cm and patients with a tumor size of 3.1–4 cm. Conclusions: In clinical T1a solid renal mass patients, LTD was associated with lower CSS and OS than LTE and PN, while LTE demonstrated noninferior CSS and superior OS to PN regardless of tumor size.Keywords
This publication has 25 references indexed in Scilit:
- Comparing Zero Ischemia Laparoscopic Radio Frequency Ablation Assisted Tumor Enucleation and Laparoscopic Partial Nephrectomy for Clinical T1a Renal Tumor: A Randomized Clinical TrialJournal of Urology, 2016
- Simple enucleation for the treatment of highly complex renal tumors: Perioperative, functional and oncological resultsEuropean Journal of Surgical Oncology, 2015
- A Prospective, Multicenter Evaluation of Predictive Factors for Positive Surgical Margins After Nephron-Sparing Surgery for Renal Cell Carcinoma: The RECORd1 Italian ProjectClinical Genitourinary Cancer, 2015
- Comparison of Partial Nephrectomy and Percutaneous Ablation for cT1 Renal MassesEuropean Urology, 2015
- Endoscopic robot-assisted simple enucleation (ERASE) for clinical T1 renal masses: description of the technique and early postoperative resultsSurgical Endoscopy, 2014
- Tumor enucleation: a safe treatment alternative for renal cell carcinomaExpert Review of Anticancer Therapy, 2011
- Incidence of benign pathologic findings at partial nephrectomy for solitary renal mass presumed to be renal cell carcinoma on preoperative imagingUrology, 2006
- Optimal Margin in Nephron-Sparing Surgery for Renal Cell Carcinoma 4 cm or LessEuropean Urology, 2003
- Prognostic importance of resection margin width after nephron-sparing surgery for renal cell carcinomaUrology, 2002
- DOES THE SIZE OF THE SURGICAL MARGIN IN PARTIAL NEPHRECTOMY FOR RENAL CELL CANCER REALLY MATTER?Journal of Urology, 2002